Benjamin Vieira

This inventor holds 1 USPTO granted patent. Top assignee: Axolabs Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Benjamin Vieira. Retrieved from https://idiyas.com/inventor/benjamin-vieira-aentmqkj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Benjamin Vieira

Introduction

Benjamin Vieira is an accomplished inventor known for his contributions to the field of medical science. He has developed innovative solutions aimed at addressing significant health challenges. His work is particularly focused on muscular dystrophy, a condition that affects many individuals worldwide.

Latest Patents

Benjamin Vieira holds a patent for "Muscle Targeting Complexes and Formulations for Treating Facioscapulohumeral Muscular Dystrophy." This patent represents a significant advancement in the treatment options available for this debilitating condition. With 1 patent to his name, Vieira's work is paving the way for new therapeutic approaches.

Career Highlights

Currently, Benjamin Vieira is associated with Axolabs GmbH, where he continues to innovate and develop new solutions in the medical field. His role at the company allows him to collaborate with other experts and contribute to groundbreaking research.

Collaborations

Throughout his career, Benjamin has worked alongside talented individuals such as Timothy Weeden and Nelson Hsia. These collaborations have enriched his work and led to the development of impactful medical solutions.

Conclusion

Benjamin Vieira's contributions to the field of medical science, particularly in treating muscular dystrophy, highlight his innovative spirit and dedication to improving patient outcomes. His work continues to inspire advancements in medical research and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…